S. Lorrain Daniel's Insider Trades & SAST Disclosures

S. Lorrain Daniel's most recent trade in Contineum Therapeutics Inc. - Ordinary Shares - Class A was a trade of 110,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 31, 2025.

Share

Note

This is a custom search result for pattern S. Lorrain Daniel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Contineum Therapeutics Inc...	Daniel S. Lorrain	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	110,000	110,000	-		-	Stock Option (right to buy)
Contineum Therapeutics Inc...	Daniel S. Lorrain	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	3,700	3,700	-		-	Stock Option (right to buy)
Contineum Therapeutics Inc...	S. Lorrain Daniel	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 16.02 per share.	25 Nov 2024	1,010	168,562	-	16.0	16,177	Class A Common Stock
Contineum Therapeutics Inc...	Daniel S. Lorrain	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 16.37 per share.	18 Nov 2024	6,091	169,671	-	16.4	99,733	Class A Common Stock
Contineum Therapeutics Inc...	Daniel S. Lorrain	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 17.05 per share.	18 Nov 2024	99	169,572	-	17.1	1,688	Class A Common Stock
Contineum Therapeutics Inc...	Daniel S. Lorrain	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 May 2024	100,000	100,000	-		-	Stock Option (right to buy)
Contineum Therapeutics Inc...	Daniel S. Lorrain	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 May 2024	3,700	3,700	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades